| Date Filed | Type | Description |
| 12/30/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
3
| WEINSTEIN ROBERT (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/24/2022 |
3
| Allen Daniel (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/23/2022 |
3
| SCHECHTER JONATHAN (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/23/2022 |
3
| STOVER JACK E (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/23/2022 |
3
| Silverman Joshua (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/23/2022 |
3
| Farb Daniel Stuart (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 04/11/2022 |
3
| Loehr Matthias (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 09/03/2021 |
3
| Trujillo Carlos (CFO) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/31/2021 |
3
| Waggoner Kenneth L. (Chairman, CEO, Pres and GC) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/31/2021 |
3
| YUEN THOMAS C K (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/31/2021 |
3
| Crabtree Gerald W (Chief Science Officer) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/20/2021 |
3
| Liquard Thomas (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/20/2021 |
3
| Tong Raymond CF (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 08/20/2021 |
3
| Abecassis Michael M (Director) has filed a Form 3 on PharmaCyte Biotech, Inc. |
| 03/30/2009 |
3
| Schmieg Martin (CEO) has filed a Form 3 on NUVILEX, INC. |
| 03/30/2009 |
3
| BARNES MARYLEW (CFO and Secretary) has filed a Form 3 on NUVILEX, INC. |